Zanella E, Rulli F, Muzi M, Sianesi M, Danese D, Sciacchitano S, Pontecorvi A
Department of Surgery, University of Rome Tor Vergata, Italy.
World J Surg. 1998 May;22(5):473-7; discussion 477-8. doi: 10.1007/s002689900419.
A retrospective study has been carried out to evaluate the prevalence of malignant thyroid tumors in 202 patients submitted to surgery for hyperthyroidism. Thyroid cancer was diagnosed in 12 cases (5.9%); the final histologic examination revealed nine papillary carcinomas, one follicular carcinoma, and two Hürthle cell carcinomas. Concurrence of hyperthyroidism and thyroid cancer was more frequent in patients with single toxic adenomas than in those with toxic diffuse or multinodular goiters. In five cases thyroid malignancy was detected in the context of the hyperthyroid lesion (three toxic adenomas and two diffuse goiters). In eight patients the malignant lesion showed a maximum diameter of less than 1 cm, although in five of these cases unfavorable histologic features, such as minimal capsular invasion or multifocality, were present. All patients presenting with thyroid cancer are currently alive and apparently free of residual disease. It is concluded that hyperthyroid patients, particularly those with single toxic adenomas, should be carefully evaluated to exclude the presence of an associated malignancy and to plan the most appropriate therapeutic options.
一项回顾性研究对202例因甲亢接受手术的患者进行了评估,以确定甲状腺恶性肿瘤的患病率。12例(5.9%)被诊断为甲状腺癌;最终组织学检查显示9例乳头状癌、1例滤泡状癌和2例许特莱细胞癌。单一毒性腺瘤患者中甲亢与甲状腺癌并存的情况比毒性弥漫性或多结节性甲状腺肿患者更常见。5例在甲亢病变背景下检测到甲状腺恶性肿瘤(3例毒性腺瘤和2例弥漫性甲状腺肿)。8例患者的恶性病变最大直径小于1厘米,尽管其中5例存在不利的组织学特征,如包膜侵犯轻微或多灶性。所有患有甲状腺癌的患者目前均存活,且显然无残留疾病。结论是,甲亢患者,尤其是单一毒性腺瘤患者,应仔细评估以排除相关恶性肿瘤的存在,并规划最合适的治疗方案。